Biologic variation of immunoglobulin free light chains in serum;Variabilità biologica delle catene leggere libere delle immunoglobuline nel siero

Biochimica Clinica

Volumn 37, Issue 5, 2013, Pages 376-382

  Braga, Federica ^a,b   Infusino, Ilenia ^a,b   Dolci, Alberto ^b   Panteghini, Mauro ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN LIGHT CHAIN;

ADULT; ARTICLE; BLOOD SAMPLING; FEMALE; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; MALE; NORMAL HUMAN; TURBIDIMETRY;

EID: 84889241837     PISSN: 03930564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Albertini R, Merlini G. La misura delle catene leggere libere delle immunoglobuline nel siero: aspetti analitici e clinici. Biochim Clin 2010;34:26-9.
2. Dolci A, Infusino I, Mozzi R, et al. Indicazioni per il corretto impiego delle indagini biochimiche nelle gammopatie monoclonali con particolare riferimento alla determinazione delle catene leggere libere delle immunoglobuline nel siero. Biochim Clin 2008;32:564-8.
3. Dispenzieri A, Kyle R, Merlini G, et al. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders. Leukemia 2009;23:215-24.
4. Dolci A, Vernocchi A per il Gruppo di Studio SIBioC Proteine. Aspetti metodologici nella ricerca e caratterizzazione delle componenti monoclonali nel siero. Biochim Clin 2012;36:84-9.
5. Tate J, Bazeley S, Sykes S, et al. Quantitative serum free light chain assay - Analytical issues. Clin Biochem Rev 2009;30:131-40.
6. Franzini C. Variabilita biologica e interpretazione degli esami di laboratorio. In: Panteghini M, ed. Interpretazione degli esami di laboratorio. Trattato Italiano di Medicina di Laboratorio. Vol VII. Padova: Piccin, 2008:13-24.
7. Fraser CG, Hyltoft Petersen P, Libeer JC, et al. Proposal for setting generally applicable quality goals solely based on biology. Ann Clin Biochem 1997;34:8-12.
8. Fraser CG, Harris EK. Generation and application of data on biological variation in clinical chemistry. Crit Rev Clin Lab Sci 1989;27:409-37.
9. Braga F, Dolci A, Mosca A, et al. Variabilità biologica dell'emoglobina glicata: un'analisi sistematica della letteratura. Biochim Clin 2009;33:297-302.
10. Tate JR, Gill D, Cobcroft R, et al. Practical considerations for the measurement of free light chains in serum. Clin Chem 2003;49:1252-7.
11. Katzmann JA, Snyder MR, Rajkumar SV, et al. Long-term biological variation of serum protein electrophoresis M-spike, urine M-spike, and monoclonal serum free light chain quantifications: implications for monitoring monoclonal gammopathies. Clin Chem 2011;57:1687-92.
12. Hansen CT, Mu{combining double acute accent}nster AM, Nielsen L, et al. Clinical and preclinical validation of the serum free light chain assay: identification of the critical difference for optimized clinical use. Eur J Haematol 2012;89:458-68.
13. Infusino I, Dolci A, Panteghini M. Valutazione delle prestazioni del sistema analitico SPAPLuS per la misura della catene leggere libere del siero. Biochim Clin 2013;37:370-5.
14. Harris EK. Effects of intra- and inter-individual variation on the appropriate use of normal range. Clin Chem 1974;20:1535-2.
15. Fraser CG, Fogarty Y. Interpreting laboratory results. Br Med J 1989;298:1659-60.
16. Fraser CG, Petersen PH. The importance of imprecision. Ann Clin Biochem 1991;28:207-11.
17. Panteghini M, Pagani F. Biological variation in bone-derived biochemical markers in serum. Scand J Clin Lab Invest 1995;55:609-16.
18. Røraas T, Petersen H, Sandberg S. Confidence intervals and power calculations for within-person biological variation: effect of analytical imprecision, number of replicates, number of samples and number of individual. Clin Chem 2012;58:1306-13.
19. Bradwell A, Harding S, Fourrier N, et al. Prognostic utility of intact immunoglobulin Igκ/Igλ ratios in multiple myeloma patients. Leukemia 2013;27:202-7.
20. Rajkumar SV, Kyle RA, Therneau TM, et al. Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance. Blood 2005;106:812-7.
21. Snozek CLH, Katzmann JA, Kyle RA, et al. Prognostic value of the serum free light chain ratio in newly diagnosed myeloma: proposed incorporation into the international staging system. Leukemia 2008;22:1933-7.
22. Zaninotto M, Altinier S, Varagnolo M, et al. Biological variation of free light chains in serum. Clin Chim Acta 2013;418:72.
23. Tate JR, Mollee P, Dimeski G, et al. Analytical performance of serum free light-chain assay during monitoring of patients with monoclonal light-chain diseases. Clin Chim Acta 2007;376:30-6.
24. Pretorius CJ, Klingberg S, Tate J, et al. Evaluation of the N Latex FLC free light chain assay on the Siemens BN analyser: precision, agreement, linearity and variation between reagent lots. Ann Clin Biochem 2012;49:450-5.
25. Wang L, Chan PCR. Measurement uncertainty for serum free light chain assays: estimation and implication on result interpretation. Clin Biochem 2013;46:381-4.